PRESS-RELEASE ·Filed May 1, 2026

LYB

LyondellBasell
NEUTRAL
Impact 4/10
Horizonmonths Processed5mo ago WireGlobeNewswire
Press release: contract
Actionable Insight • Neutral

Monitor LYB's upcoming earnings calls for quantification of the divestiture's impact on revenue, margins, and capital allocation plans. The lack of disclosed deal value limits immediate trading catalyst, but the strategic shift toward higher-return assets is a positive long-term signal.

DirectionNeutral
Confidencemedium
Horizonmonths
Final — all horizons settled through T+60d ⚠ clustered
LYB ▼ -21.57% at T+60d
NEUTRAL call ✗ call lost -21.57% · α vs SPY -24.13% · entry $74.75 → $58.62
Entry anchored
May 1, 2026
via day open
T+1d
+1.59%
call +1.59% · α +1.93%
$75.94
settled 5mo ago
T+5d
-4.40%
call -4.40% · α -6.75%
$71.46
settled 5mo ago
T+20d
-10.17%
call -10.17% · α -15.46%
$67.14
settled 4mo ago
T+60d
-21.57%
call -21.57% · α -24.13%
$58.62
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

LyondellBasell completed the sale of select European olefins and polyolefins assets to AEQUITA, a key step in its European strategic assessment. The divestiture refines the portfolio toward higher-return assets and enhances financial flexibility, but the deal value was not disclosed, limiting immediate financial impact assessment.

Key Facts

  • Sale of European olefins and polyolefins assets in France, Germany, UK, and Spain to AEQUITA completed.
  • Deal value not disclosed in the press release.
  • Divested business will operate as Velogy under AEQUITA ownership.
  • LYB retains Advanced Polymer Solutions business in Tarragona, Spain.
  • Citi and J.P. Morgan acted as financial advisors; Linklaters as legal counsel.
  • Transaction supports LYB's strategy to focus on assets with durable competitive advantages and stronger long-term returns.

Financial Impact

Deal value undisclosed; no financial terms provided.

portfolio compositionfinancial flexibilitycapital allocation

Risk Factors

  • Undisclosed deal value leaves uncertainty about financial impact and potential one-time charges.
  • Transition of employees and operations to Velogy may cause short-term disruptions.
  • Remaining European operations may face ongoing regulatory or market headwinds.

Market Snapshot

Exchange
NYSE
Sector
Industrial Organic Chemicals
Analyst Consensus
36% bullish (25 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3285747
12 reports for LYB
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for LYB — sortable, filterable
TypeNow
Jul 31, 2026
9w ago
8-K
BULLISH ★ 6/10
$62.08 $63.67▲ +2.56%▼ −0.43%$58.58 (−5.63%)
Jul 7, 2026
12w ago
Press Release
NEUTRAL ★ 2/10
$54.60 $60.62▲ +11.03%▲ +9.69%$58.58 (+7.30%)
Jul 6, 2026
12w ago
Press Release
NEUTRAL ★ 2/10
$52.97 $62.08▲ +17.20%▲ +17.76%$58.58 (+10.60%)
May 29, 2026
17w ago
8-K
NEUTRAL ★ 3/10
$67.13 $53.62▼ −20.12%▼ −17.81%$58.58 (−12.72%)
May 22, 2026
19w ago
Press Release
NEUTRAL ★ 2/10
$69.65 $58.52▼ −15.97%▼ −15.81%$58.58 (−15.88%)
May 1, 2026
22w ago
Press Release
MIXED ★ 6/10
$74.75 $67.14▼ −10.17%▼ −15.46%$58.58 (−21.62%)
May 1, 2026
22w ago
Press Release
NEUTRAL ★ 4/10
$74.75 $67.14▼ −10.17%▼ −15.46%$58.58 (−21.62%)
Apr 10, 2026
25w ago
Press Release
NEUTRAL ★ 2/10
$73.69 $71.51▼ −2.95%▼ −11.48%$58.58 (−20.49%)
Apr 10, 2026
25w ago
DEFA14A
NEUTRAL ★ 3/10
$73.69 $71.51▼ −2.95%▼ −11.48%$58.58 (−20.49%)
Apr 6, 2026
25w ago
Press Release
NEUTRAL ★ 3/10
$78.60 $75.94▼ −3.38%▼ −12.37%$58.58 (−25.46%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (65h 26m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 1, 2026